Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Dec 1.

Published in final edited form as: Clin Breast Cancer. 2019 Jun 6;19(6):e741–e747. doi: 10.1016/j.clbc.2019.05.014

Table 1:

Patient demographics

		All, # (%) N= 38,864	pCR, # (% of All) N=7,432
cT Stage	1	7,958 (21)	1,631 (20)
	2	21,406 (55)	4,393 (21)
	3	9,500 (24)	1,408 (15)
Receptor status	ER/PR+Her2−	17,424 (45)	1,519 (9)
	ER/PR+Her2+	6,871 (18)	1,537 (22)
	ER−PR−Her2−	10,756 (28)	2,934 (27)
	ER−PR−Her2+	3,813 (10)	1,442 (38)
Clinical Nodal disease	Absent	16,783 (43)	3,086 (18)
Clinical Nodal disease	Present	22,081 (57)	4,346 (20)
Age	<45	10,819 (28)	2,277 (21)
	45–55	13,783 (36)	2,610 (19)
	>55	14,262 (37)	2,545 (18)
Race	White	29,731 (77)	5,637 (19)
	Non-White	8,805 (23)	1,734 (20)
	Unknown	325 (1)	61 (19)
Ethnicity	Non-Hispanic	36,035 (93)	6,885 (19)
Ethnicity	Hispanic	2,829 (7)	547 (19)
Insurance	Private	25,889 (67)	5,147 (20)
	Uninsured	1,612 (4)	323 (20)
	Medicaid	4,649 (12)	820 (18)
	Gov’t/Medicare	6,257 (16)	1,058 (17)
	Unknown	457 (1)	84 (18)